In a breast cancer xenograft model, the CXCR4-specific inhibitor AMD3100 [206] successfully mobilized dormant tumor cells out of the perisinusoidal niche of the BM, as demonstrated with real-time in vivo imaging [207]. This evidence concerns the gene CXCR4 and neoplasm.